Atherosclerotic Risk Factor Prevalence in Adults With Congenital Heart Disease
Αndreas S. Papazoglou(Aristotle University of Thessaloniki), George Giannakoulas(AHEPA University Hospital), Konstantinos Dimopoulos(Guy's and St Thomas' NHS Foundation Trust), Αναστάσιος Κάρτας(Aristotle University of Thessaloniki), Konstantinos G. Kyriakoulis(National and Kapodistrian University of Athens), Dimitrios V. Moysidis(Aristotle University of Thessaloniki), Maria Chatzi(Athens Naval & Veterans Hospital), Amalia Baroutidou(Aristotle University of Thessaloniki), Vasileios Kamperidis(Aristotle University of Thessaloniki), Konstantinos Barmpagiannos(AHEPA University Hospital), Antonios Ziakas(Aristotle University of Thessaloniki)
Cited by 9
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus
|Circulation|2023|113
COVID-19 in Adults With Congenital Heart Disease
|Journal of the American College of Cardiology|2021|76
Prognostic significance of diabetes mellitus in patients with atrial fibrillation
|Cardiovascular Diabetology|2021|48